Otsuka

Japan - TokushimaBiotechnology2 H-1B visas (FY2023)

Focus: Otsuka is a Japan-based specialty pharmaceutical company focused on small-molecule therapies across neurology, psychiatry, nephrology, hematology, and oncology. The company generates 84% of revenue from a single product (REXULTI), indicating a highly concentrated commercial portfolio.

Neurology Nephrology Hematology Psychiatry

Profile data last refreshed 13h ago · AI intelligence enriched 1w ago

Open Jobs

About Otsuka

AI assessmentNot Hiring

No open roles listed right now. Follow Otsuka to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

3/9 — Basic

Company HealthWatch

Pipeline

Early-stage

50 total

LOE Risk

4 imminent

ABILIFY

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Key Products

REXULTI

Atypical Antipsychotic

$630M Part D

Peak6.7yr

Flagship product generating 84% of company revenue; faces 9-year patent exclusivity with peak lifecycle status.

Help build intelligence for Otsuka

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Pipeline & Clinical Trials

Brexpiprazole

Alzheimer Disease

N/A

Clinical Trials (1)

NCT06875986REXULTI Drug General Use-results Survey (Excessive Motor Activity or Physically/Verbally Aggressive Behavior Due to Rapid Changes in Mood, Irritability, and/or Outbursts Associated With Dementia Due to Alzheimer's Disease)

N/A

Standard stenting

Peripheral Arterial Disease

N/A

Clinical Trials (1)

NCT05759819Evaluate the Efficacy and Safety of the Cilostazol-coated BioMimics 3D Stent System in Patients with Peripheral Arterial Occlusive Disease

N/A

Observational Study in Patients With Autosomal Dominant Polycystic Kidney Disease

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

N/A

Clinical Trials (1)

NCT01430494Observational Study in Patients With Autosomal Dominant Polycystic Kidney Disease

N/A

Tolvaptan

Safety

N/A

Clinical Trials (1)

NCT03406286Samsca PMS in ADPKD Patients

N/A

Nalmefene Hydrochloride Hydrate

Alcohol Dependence

N/A

Clinical Trials (1)

NCT04107051Post-Marketing Surveillance Study of Nalmefene Hydrochloride Hydrate in Patients with Alcohol Dependence

N/A

Cilostazol

Tinnitus

N/A

Clinical Trials (1)

NCT01378650A Study on the Effect of Cilostazol in Patients With Chronic Tinnitus

N/A

Abilify Maintena PMS in Schizophrenia Patients or Bipolar 1 Disorder

Schizophrenia

N/A

Clinical Trials (1)

NCT03386851Abilify Maintena PMS in Schizophrenia Patients or Bipolar 1 Disorder

N/A

Brexpiprazole

Psychosis

N/A

Clinical Trials (1)

NCT05962216Real-life Assessment of Brexpiprazole (Rexulti) in Schizophrenia and in Depressive Disorders

N/A

Aripiprazole

Schizophrenia

N/A

Clinical Trials (1)

NCT00216723Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar Disorder

N/A

Voclosporin

Lupus Nephritis

N/A

Clinical Trials (1)

NCT07053891LUPKYNIS Drug-use Results Survey

N/A

Clinical Implications of DNA Analysis on ADPKD

Autosomal Dominant Polycystic Kidney Disease

N/A

Clinical Trials (1)

NCT02322385Clinical Implications of DNA Analysis on ADPKD

N/A

OPC-61815 injection 2mg

Congestive Heart Failure

N/A

Clinical Trials (1)

NCT03254108Clinical Pharmacology Trial to Investigate the Dose of OPC-61815 Injection Equivalent to Tolvaptan 15-mg Tablet in Patients With Congestive Heart Failure

N/A

Fremanezumab 225 Mg/1.5 mL Subcutaneous Solution

Migraine Disorders

N/A

Clinical Trials (1)

NCT05342493Specified Drug Use Survey on AJOVY Subcutaneous Injection for Long-term Use

N/A

Consumption of soy protein bar

Menopause

N/A

Clinical Trials (1)

NCT07136220A Pilot Study to Evaluate Equol and Its Effects on Menopausal Symptoms Experienced by Women in Singapore

N/A

Effect on Metabolic Parameters of Abilify in SPR

Schizophrenia

N/A

Clinical Trials (1)

NCT00569764Effect on Metabolic Parameters of Abilify in SPR

N/A

Clopidogrel 75mg

Coronary Heart Disease

N/A

Ponatinib

Chronic Myeloid Leukemia

N/A

Clinical Trials (1)

NCT03709017Iclusig PMS in CML or Ph+ALL Patients

N/A

Samsca Post Marketing Surveillance Study

Hypervolemic and Euvolemic Hyponatremia

N/A

Clinical Trials (1)

NCT02722863Samsca Post Marketing Surveillance Study

N/A

Efficacy and Safety of Cilostazol for the Indication of CSPS

Cerebral Infarction

N/A

Clinical Trials (1)

NCT00216749Efficacy and Safety of Cilostazol for the Indication of CSPS

N/A

tolvaptan

Polycystic Kidney, Autosomal Dominant

N/A

Clinical Trials (1)

NCT02847624Post-Marketing Surveillance Study of Tolvaptan in Patients With ADPKD

N/A

Improving Cognitive Function of Aripiprazole in Treating Adolescents and Young Adults With Psychotic

Psychotic Disorders

N/A

Clinical Trials (1)

NCT00541502Improving Cognitive Function of Aripiprazole in Treating Adolescents and Young Adults With Psychotic Disorder

N/A

Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients

Schizophrenia

N/A

Clinical Trials (1)

NCT01043250Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients

N/A

ABF Tourette's Disorder Post Marketing Surveillance Study

Tourette's Disorder

N/A

Clinical Trials (1)

NCT01795105ABF Tourette's Disorder Post Marketing Surveillance Study

N/A

Tolvaptan

Antidiuretic Hormone, Inappropriate Secretion

N/A

Clinical Trials (1)

NCT04790175Samsca Post-marketing General Drug Use-results Survey in Patients With Hyponatremia in SIADH

N/A

Abilify prolonged release aqueous suspension for IM injection

Bipolar Disorder I

N/A

Clinical Trials (1)

NCT04812379Specified Drug-use Survey on Abilify Prolonged Release Aqueous Suspension for IM Injection (Prevention of Relapse of Mood Episodes in BP)

N/A

Real Life Assessment of Abilify Maintena

Schizophrenia

N/A

Clinical Trials (1)

NCT02131415Real Life Assessment of Abilify Maintena

N/A

Aripiprazole oral product

Autism

N/A

Clinical Trials (1)

NCT03179787Post-Marketing Surveillance Study of Aripiprazole in Patients With Autism

N/A

CDI Pts

Clostridium Difficile Infection

N/A

Clinical Trials (1)

NCT02223715Prospective Observational Study of Clostridium Difficile Infection in Asian Pacific Countries

N/A

Samtasu for I.V. infusion

Heart Failure

N/A

Clinical Trials (1)

NCT05712746Samtasu Post-marketing General Drug Use-results Survey in Patients With Volume Overload in Heart Failure.

N/A

Adacolumn®

Ulcerative Colitis

N/A

Clinical Trials (1)

NCT00781638ADAPT Adacolumn Pediatric Trial in Ulcerative Colitis

N/A

Study on the Efficacy and Safety of Oral Probucol Tablets in Patients With Hyperlipidemia - Post-Mar

Hyperlipidemia

N/A

Clinical Trials (1)

NCT02730390Study on the Efficacy and Safety of Oral Probucol Tablets in Patients With Hyperlipidemia - Post-Marketing Surveillance

N/A

Brexpiprazole

Schizophrenia

N/A

Clinical Trials (1)

NCT04641780"Brexpiprazole (Rexulti™) Safety and Efficacy Among Filipino Patients (RAISE) - A Post Marketing Surveillance Program"

N/A

Retrospective Database Study of Real World Abilify Outcomes in Major Depressive Disorder (MDD)

Depressive Disorder, Major

N/A

Clinical Trials (1)

NCT01284218Retrospective Database Study of Real World Abilify Outcomes in Major Depressive Disorder (MDD)

N/A

Tolvaptan

Brain Injury

N/A

Clinical Trials (1)

NCT02215148Pharmacokinetics and Clinical Response of Tolvaptan in Neurocritical Care Patients

N/A

An Observational Study Measuring Outcomes in Cancer Patients Treated for Moderate to Severe Hyponatr

Hyponatremia

N/A

Clinical Trials (1)

NCT02573077An Observational Study Measuring Outcomes in Cancer Patients Treated for Moderate to Severe Hyponatremia in Italy

N/A

An Observational Study on Real-world Use and Outcomes of Patients Treated With Tolvaptan for Hyponat

Hyponatremia

N/A

Clinical Trials (1)

NCT02545101An Observational Study on Real-world Use and Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to SIADH

N/A

Tolvaptan

Cystinuria

N/A

Clinical Trials (1)

NCT02538016TCUPS- Tolvaptan Use in Cystinuria and Urolithiasis: A Pilot Study

N/A

MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia

Acute Myeloid Leukemia

N/A

Clinical Trials (1)

NCT01385787MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia

N/A

Predictors of Persistence in Patients With Schizophrenia Treated With Once-monthly Aripiprazole in S

Schizophrenia

N/A

Clinical Trials (1)

NCT03130478Predictors of Persistence in Patients With Schizophrenia Treated With Once-monthly Aripiprazole in Spain

N/A

A Study Measuring Quality of Life, Treatment Preference and Satisfaction of ADPKD Patients in Europe

Autosomal Dominant Polycystic Kidney Disease

N/A

Clinical Trials (1)

NCT02848521A Study Measuring Quality of Life, Treatment Preference and Satisfaction of ADPKD Patients in Europe

N/A

Standard Triple Therapy

Helicobacter Infection

N/A

Clinical Trials (1)

NCT01723059Standard Triple Therapy vs Sequential Therapy in Treatment of H Pylori Infection

N/A

Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects Wi

Bipolar 1 Disorder

N/A

Clinical Trials (1)

NCT02050854Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or Schizophrenia

N/A

An Observational Study to Describe the Adherence to the SEOM Algorithm for the Treatment of Hyponatr

Hyponatremia

N/A

Clinical Trials (1)

NCT02548845An Observational Study to Describe the Adherence to the SEOM Algorithm for the Treatment of Hyponatraemia in Spain

N/A

Adacolumn®

Ulcerative Colitis

N/A

Clinical Trials (1)

NCT00366925CESA 5.10 Investigation to Compare the Efficacy and Safety of the Adacolumn® Apheresis Device in Patients With Active Ulcerative Colitis

N/A

Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia

Euvolemic Hyponatremia

N/A

Clinical Trials (1)

NCT01240668Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia

N/A

Aripiprazole

Major Depressive Disorder

N/A

Clinical Trials (1)

NCT01488266Aripiprazole Augmentation Versus Switching to Different Class of Antidepressants in Major Depressive Disorder

N/A

CT-152 - Digital Therapeutic

Major Depressive Disorder

N/A

Clinical Trials (1)

NCT04770285Trial to Evaluate the Effectiveness of a Digital Therapeutics in Adults Diagnosed With Major Depressive Disorder

N/A

Aripiprazole Once-Monthly

Schizophrenia

N/A

Clinical Trials (1)

NCT04907279Aripiprazole Once-Monthly in Hospitalized Patients (INITIATE)

N/A

Carer Treatment Preference Myelodysplasia Questionnaire

Myelodysplastic Syndrome (MDS)

N/A

Clinical Trials (1)

NCT05817331Refine and Assess the Readability of Patient, Carer, and Clinician Treatment Preference in Myelodysplasia Questionnaire

N/A

Tolvaptan

SIADH

N/A

Clinical Trials (1)

NCT01228682Post-Authorisation Safety Study of Samsca (Tolvaptan) Used in Routine Medical Practice

N/A

Otsuka

About Otsuka

Why Work Here

Key Products

Watch Out For

Products & Portfolio (29)

Key Products by Revenue

Other Products (27)

Pipeline & Clinical Trials

Open Jobs (0)

Hiring Trend

Visa Sponsorship

Risk Signals